Allergen extracts are prepared according to the sensitivities of the individual. The extracts are administered at regular intervals to induce a response called immune tolerance. The tolerance response is achieved by the production of blocking antibodies and regulatory T cells. When this happens, the patient’s sensitivity to the allergens progressively diminishes, and symptoms also decline. Studies have shown that after three to five years of treatment, the effectiveness persists long-term even after treatment is discontinued.
Allergic rhinitis in childhood is a risk factor for the development of asthma. A study shows that children who received allergen immunotherapy for allergic rhinitis have 2.5-fold reduced risk of developing asthma. This effect is still evident 10 years after treatment.
Recent studies have also shown that for a subset of patients with atopic dermatitis, where environmental allergy is a major factor in their illness, immunotherapy is effective in reducing the severity of their skin disease.
Allergen immunotherapy has traditionally been administered by subcutaneous injections. Newer forms of treatment such as sublingual immunotherapy have been developed that are more convenient, and maybe suitable for selected patients
Reference information: http://www.allergy.hk
The information aims to provide educational purpose only. Anyone reading it should consult physician before considering treatment and should not rely on the information above.
No comments:
Post a Comment